These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2767014)

  • 1. The neuropathology of vigabatrin.
    Butler WH
    Epilepsia; 1989; 30 Suppl 3():S15-7. PubMed ID: 2767014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats.
    Butler WH; Ford GP; Newberne JW
    Toxicol Pathol; 1987; 15(2):143-8. PubMed ID: 3616399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats.
    Valdizán EM; Armijo JA
    Epilepsia; 1991; 32(5):735-42. PubMed ID: 1915185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of single and multiple increasing doses of vigabatrin on brain GABA metabolism and correlation with vigabatrin plasma concentration.
    Valdizán EM; Armijo JA
    Biochem Pharmacol; 1992 May; 43(10):2143-50. PubMed ID: 1599502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of vigabatrin.
    Sabers A; Gram L
    Pharmacol Toxicol; 1992 Apr; 70(4):237-43. PubMed ID: 1608908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-vinyl GABA: comparison of neurochemical and anticonvulsant effects in mice.
    Bernasconi R; Klein M; Martin P; Christen P; Hafner T; Portet C; Schmutz M
    J Neural Transm; 1988; 72(3):213-33. PubMed ID: 3418334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vigabatrin and of GABA on myelinated rat cerebellar cultures: preliminary data.
    Hauw JJ; Boutry JM; Sun P; Sazdovitch V; Duyckaerts C
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):47S-52S. PubMed ID: 2757909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor.
    Gibson JP; Yarrington JT; Loudy DE; Gerbig CG; Hurst GH; Newberne JW
    Toxicol Pathol; 1990; 18(2):225-38. PubMed ID: 2399411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vigabatrin on the electroencephalogram in rats.
    Halonen T; Pitkänen A; Koivisto E; Partanen J; Riekkinen PJ
    Epilepsia; 1992; 33(1):122-7. PubMed ID: 1733745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential neuropathology of dogs treated with vigabatrin, a GABA-transaminase inhibitor.
    Yarrington JT; Gibson JP; Dillberger JE; Hurst G; Lippert B; Sussman NM; Heydorn WE; Marler RJ
    Toxicol Pathol; 1993; 21(5):480-9. PubMed ID: 8115824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term vigabatrin on somatosensory-evoked potentials in epileptic patients.
    Liegeois-Chauvel C; Marquis P; Gisselbrecht D; Pantieri R; Beaumont D; Chauvel P
    Epilepsia; 1989; 30 Suppl 3():S23-5. PubMed ID: 2767016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI findings in epileptic patients on vigabatrin for more than 5 years.
    Cocito L; Maffini M; Loeb C
    Seizure; 1992 Sep; 1(3):163-5. PubMed ID: 1344761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain.
    Sidhu RS; Del Bigio MR; Tuor UI; Seshia SS
    Exp Neurol; 1997 Apr; 144(2):400-5. PubMed ID: 9168839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micro-vacuolation in rat brains after long term administration of GABA-transaminase inhibitors. Comparison of effects of ethanolamine-O-sulphate and vigabatrin.
    John RA; Rimmer EM; Williams J; Cole G; Fowler LJ; Richens A
    Biochem Pharmacol; 1987 May; 36(9):1467-73. PubMed ID: 3579985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental studies and controlled clinical testing of valproate and vigabatrin.
    Gram L
    Acta Neurol Scand; 1988 Oct; 78(4):241-70. PubMed ID: 3146860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats.
    Halonen T; Pitkänen A; Saano V; Riekkinen PJ
    Epilepsia; 1991; 32(2):242-9. PubMed ID: 1672276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One to three day dose intervals during subchronic treatment of epileptic gerbils with gamma-vinyl GABA: anticonvulsant efficacy and alterations in regional brain GABA levels.
    Löscher W; Frey HH
    Eur J Pharmacol; 1987 Nov; 143(3):335-42. PubMed ID: 3691661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
    Arteaga R; Herranz JL; Valdizán EM; Armijo JA
    Epilepsia; 1992; 33(5):923-31. PubMed ID: 1396437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma.
    Löscher W; Hörstermann D
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):270-8. PubMed ID: 8208305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology of vigabatrin.
    Graham D
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):43S-45S. PubMed ID: 2757908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.